News

Biomoda currently is conducting clinical trials of its CyPath labeling solution, an inexpensive, noninvasive assay designed to identify early-stage lung cancer by binding to cancer cells and causing

The new, five-building, EUR77m B Braun manufacturing campus includes a plant dedicated to producing infusion pumps as well as facilities for research and development, services and training. With

Motavizumab (proposed INN, trade name Numax) is a humanised monoclonal antibody. It is being investigated by MedImmune for the prevention of respiratory syncytial virus infection in high-risk infants.

BioGaia said that the launch of the product is estimated at the end of 2011 following relevant local registration which will be taken care of by Asia United.

Everolimus is approved under the trade name Afinitor (everolimus) tablets for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or

The new patent is titled ‘Regioselective and Stereoselective Oxidation of Fused Ring Systems Useful for the Preparation of Aminosterols’. It marks the first patent issued for this intellectual

Recently, FDA requested manufacturers to revise their drug labels because of an increased risk of severe exacerbation of asthma symptoms, leading to hospitalizations, in pediatric and adult patients,

Life Technologies said that the pilot study builds upon a research trial announced earlier this year in association with TGen and US Oncology, to sequence the genomes of

Under the terms of the agreement, Perceptive Imagineering will represent RPC and conduct product registration, marketing, sales and support for the licensing and distribution of Onko-Sure as a